Xortx Therapeutics Inc
(XRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 12-2020 | 11-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,318 | -8,537 | -1,948 | -959 | -21,211 |
| Depreciation Amortization | 14 | 10 | 7 | 15 | 17,817 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 16,387 |
| Accounts receivable | -30 | N/A | N/A | N/A | 42,082 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | -15,064 |
| Other Working Capital | -1,099 | -318 | -544 | 270 | 50,387 |
| Other Operating Activity | -2,405 | 7,169 | 831 | 130 | -23,860 |
| Operating Cash Flow | $-4,837 | $-1,675 | $-1,654 | $-544 | $66,538 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 0 | -17,161 |
| Purchase Sale Intangibles | -32 | -18 | -9 | N/A | -1,355 |
| Other Investing Activity | -32 | -18 | -9 | -11 | -1,355 |
| Investing Cash Flow | $-32 | $-18 | $-9 | $-11 | $-18,516 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,197 | 6,113 | 5,810 | N/A | 30 |
| Dividend Paid | N/A | N/A | N/A | 0 | -62,234 |
| Other Financing Activity | -683 | -586 | -95 | 639 | 0 |
| Financing Cash Flow | $19,514 | $5,528 | $5,715 | $639 | $-62,204 |
| Exchange Rate Effect | 260 | N/A | N/A | 0 | N/A |
| Beginning Cash Position | 137 | 136 | 139 | 44 | 117,174 |
| End Cash Position | 15,041 | 3,970 | 4,192 | 128 | 102,992 |
| Net Cash Flow | $14,905 | $3,834 | $4,053 | $84 | $-14,182 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,837 | -1,675 | -1,654 | -544 | 66,538 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -17,161 |
| Free Cash Flow | -4,837 | -1,675 | -1,654 | -544 | 49,377 |